LANNETT CO INC FDA Approval ANDA 202386

ANDA 202386

LANNETT CO INC

FDA Drug Application

Application #202386

Application Sponsors

ANDA 202386LANNETT CO INC

Marketing Status

Discontinued001

Application Products

001SOLUTION;ORAL1MG/ML0RISPERIDONERISPERIDONE

FDA Submissions

UNKNOWN; ORIG1AP2015-01-12

Submissions Property Types

ORIG1Null17

TE Codes

001PrescriptionAA

CDER Filings

LANNETT CO INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202386
            [companyName] => LANNETT CO INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"RISPERIDONE","activeIngredients":"RISPERIDONE","strength":"1MG\/ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/12\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2015-01-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.